| ²é¿´: 484 | »Ø¸´: 3 | |||
dtjbxyľ³æ (ÖøÃûдÊÖ)
|
[½»Á÷]
¡¾ÇóÖú¡¿ßäàÄªÌØÅ·ÖÞÒ©µä ÒÑÓÐ3È˲ÎÓë
|
|
±¾ÈËÓûÇóÖúßäàÄªÌØÅ·ÖÞÒ©µä£¬ßäàÄªÌØÓ¢ÎÄÃû: Imiquimod CAS: 99011-02-6 |
» ²ÂÄãϲ»¶
·ÇÈ«ÈÕÖÆ¹«¹²¹ÜÀíÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ҩѧ298·Ö-Ò»Ö¾Ô¸Öйúº£Ñó´óѧ-Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ147È˻ظ´
¡¾#ÉϺ£µ÷¼Á¼±Â¼#¡¿ÄܽÓÊÜ985ÁªºÏÅàÑøµÄËÙÀ´£¡´øÄã·¢Ò»ÇøÎÄÕ£¡
ÒѾÓÐ3È˻ظ´
¡¾ÉϺ£µ÷¼Á¡¿985ÁªºÏÅàÑø£¡±ð´í¹ýÄÜËÍÄãÈ¥µ¤Âó/½»´ó/ͬ¼Ã/ÖпÆÔºµÄÉñÏɵ¼Ê¦£¡
ÒѾÓÐ0È˻ظ´
¡¾µ÷¼ÁÉϰ¶¡¿985ÁªºÏÅàÑø£¡1007/1055/08/07µÈ£¬²»ÏÞרҵ£¬ÏëÁªÅàµÄËÙÀ´£¡
ÒѾÓÐ1È˻ظ´
¡¾ÉϺ£µ÷¼Á¡¿985ÁªºÏÅàÑø£¡±ð´í¹ýÄÜËÍÄãÈ¥µ¤Âó/½»´ó/ͬ¼Ã/ÖпÆÔºµÄÉñÏɵ¼Ê¦£¡
ÒѾÓÐ4È˻ظ´
¡¾#ÉϺ£µ÷¼Á¼±Â¼#¡¿ÄܽÓÊÜ985ÁªºÏÅàÑøµÄËÙÀ´£¡´øÄã·¢Ò»ÇøÎÄÕ£¡
ÒѾÓÐ4È˻ظ´
zfuchang
½ð³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 11 (СѧÉú)
- ½ð±Ò: 3107
- É¢½ð: 920
- ºì»¨: 2
- ɳ·¢: 1
- Ìû×Ó: 1117
- ÔÚÏß: 269.4Сʱ
- ³æºÅ: 180418
- ×¢²á: 2006-02-09
- ÐÔ±ð: GG
- רҵ: Óлú»¯¹¤
2Â¥2010-05-26 10:17:35
dtjbxy
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 197 (¸ßÖÐÉú)
- ¹ó±ö: 0.068
- ½ð±Ò: 5258.4
- É¢½ð: 301
- ºì»¨: 14
- Ìû×Ó: 1286
- ÔÚÏß: 174.6Сʱ
- ³æºÅ: 99692
- ×¢²á: 2005-11-11
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
3Â¥2010-05-26 10:21:56
zhxchem
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 7425.9
- É¢½ð: 31
- ºì»¨: 2
- Ìû×Ó: 1590
- ÔÚÏß: 969.2Сʱ
- ³æºÅ: 672488
- ×¢²á: 2008-12-11
- רҵ: Ò©Îﻯѧ
|
Monograph Number: 0004922 Title: Imiquimod CAS Registry Number: 99011-02-6 CAS Name: 1-(2-Methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine Additional Names: 4-amino-1-isobutyl-1H-imidazo[4,5-c]quinoline Manufacturers' Codes: R-837; S-26308 Trademarks: Aldara (3M Pharma) Molecular Formula: C14H16N4 Molecular Weight: 240.30 Percent Composition: C 69.97%, H 6.71%, N 23.32% Literature References: Immune response modifier; stimulates production of interferon-a, q.v. Prepn: J. F. Gerster, EP 145340; idem, US 4689338 (1985, 1987 both to Riker). Mechanism of action study: K. Megyeri et al., Mol. Cell. Biol. 15, 2207 (1995). Clinical pharmacology: P. L. Witt et al., Cancer Res. 53, 5176 (1993). Clinical trial for genital warts: L. Edwards et al., Arch. Dermatol. 134, 25 (1998). Series of articles on pharmacology and clinical experience in cutaneous viral infections: J. Am. Acad. Dermatol. 43, S1-S30 (2000). Properties: Crystals from DMF, mp 292-294¡ã. Melting point: mp 292-294¡ã Therap-Cat: Antiviral; immunomodulator. Keywords: Immunomodulator; Antiviral; Imidazoquinolines. |
4Â¥2010-05-26 14:24:25














»Ø¸´´ËÂ¥